(muscle, liver, and kidney) of 18 turkeys were determined after continuous administration of the drug for 3 days in drinking water at the maximum recommended concentration of 400 mg/L. The European Union (EU) maximum residue limits (MRLs) set for OTC are 100 mg/kg in muscle tissues, 300 mg/kg in liver, and 600 mg/kg in kidney, as the sum of the parent compound and its derivative 4¢-epi-oxytetracycline (4-epi-OTC). Cleanup of tissue samples was performed by metal chelate affinity chromatography (MCAC), but the original technique was miniaturized by the adoption of a mini solid-phase extraction column, allowing reduction of solvents, time, and hazardous waste. OTC and its 4¢-epimer were quantitated by an isocratic liquid chromatography elution with UV detection. After 1 day of withdrawal, OTC plus 4-epi-OTC residues were greater than MRL values in muscle and liver; 3 days after the end of treatment, all tissue residues were far lower than the MRL values. At the first day after the end of treatment, 4-epi-OTC was detected at very low concentrations only in muscle, in liver after 1 and 3 days of withdrawal, and in kidney at all sampling times. The withdrawal time was calculated according to EU recommendations and was set at 5 days.
O xytetracycline (OTC) is a broad spectrum antibiotic widely used in veterinary medicine for the treatment and control of a variety of bacterial infections. Its widespread use raises the possibility that residues may remain in animal tissues intended for human consumption.
Italy is a great producer and consumer of turkey meat, and OTC is widely used there for the treatment of respiratory and intestinal infections in turkeys. It is administered in drinking water at concentrations ranging from 200 to 400 mg/L to guarantee a dose rate of 40-80 mg/kg.
The European Union (EU) maximum residue limits (MRLs) set for OTC are 100 m g/kg in muscle tissues and milk, 200 m g/kg in eggs, 300 m g/kg in liver, and 600 m g/kg in kidney, measured as the sum of the parent compound and its derivative, 4¢ -epi-oxytetracycline (4-epi-OTC; 1). Considerable research has been done on the determination of OTC residues in eggs (2, 3) , milk (4-6), pig (7) , sheep (7) , and calf (8, 9) tissues. However, no recent scientific data are available for OTC residue studies in chicken (10) or turkey tissues (11) .
The purpose of this work was to determine the residue depletion of OTC in edible tissues of turkeys after oral administration of the drug in drinking water at the maximum recommended concentration of 400 mg/L. The method adopted was based on a miniaturized solid-phase extraction procedure to reduce the amount of solvents and time, and liquid chromatgraphic (LC) elution at isocratic condition to simultaneously detect OTC and 4-epi-OTC. Based on the tissue residues, a withdrawal time was calculated according to Guideline No. EMEA/CVMP/036/95 of the Committee for Veterinary Medicinal Products (12) .
Experimental

Birds and Treatment
Thirty cross-bred healthy turkeys of both sexes, 3 weeks old, were purchased from a local supplier and housed in floor pens with free access to fresh water and a standard commercial OTC-free diet. The pens had natural light, 60% relative humidity, and a temperature maintained at 26°C by means of heat lamps. After a 15-day acclimatization period, 18 birds, each weighing 1.35 ± 0.15 kg, received a commercial preparation OTC hydrochloride (97% purity) in the drinking water (400 mg/L) for 3 consecutive days; 12 birds, each weighing 1.34 ± 0.14 kg, used as controls, received tap water. The medi-cated water was freshly prepared each day by dissolving 4.4 g OTC hydrochloride in 10 L tap water. The OTC concentration in medicated water and its consumption were checked at the beginning and end of each day. The mean (± standard deviation) concentration of OTC hydrochloride in medicated water was 401 ± 3 mg/L, and the water intake varied from 142 mL/kg body weight (bw) during the first day of treatment to 258 mL/kg bw during the last day of treatment. Six treated and 4 control birds were killed at days 1, 3, and 5 after the end of treatment, and samples of liver (whole), kidney (both), and muscle (100 g) were immediately collected, kept on ice, and transported to the laboratory. Sample fortification was performed by adding solutions (c1), (c2), and (c3) on the surface of the homogenized tissues and mixing on a vortex mixer for ca 30 s. Volumes were as follows: muscle: add 40 m L solutions (c1), (c2), and (c3) to obtain OTC concentrations of 50, 100, and 200 m g/kg and 4-epi-OTC concentrations of 12.5, 25, and 50 m g/kg, respectively; liver: add 120 m L solutions (c1), (c2), and (c3) to obtain OTC concentrations of 150, 300, and 600 m g/kg and 4-epi-OTC concentrations of 37.5, 75, and 150 m g/kg, respectively; kidney: add 60, 120, and 240 m L solution (c3) to obtain OTC concentrations of 300, 600, and 1200 m g/kg and 4-epi-OTC concentrations of 75, 150, and 300 m g/kg, respectively.
Apparatus
The concentrations of 4-epi-OTC were arbitrarily established at one-fourth of OTC concentrations, considering that the amount of the OTC derivative in incurrent samples should not exceed this ratio.
Sample Preparation and Extraction
Tissues were cut with scissors into small pieces, minced in a Waring laboratory blender, and immediately homogenized with an Ultraturrax (IKA labortecknik). The homogenates were stored at -80°C pending extraction. After thawing at room temperature, 1 g tissue from control animals (blank samples) was weighed, placed in a polypropylene tube, and fortified with OTC at 50, 100, 200 m g/kg (muscle); 150, 300, 600 m g/kg (liver); 300, 600, 1200 m g/kg (kidney), and with 4-epi-OTC at 12.5, 25, 50 m g/kg (muscle); 37.5, 75, 150 m g/kg (liver), and 75, 150, 300 m g/kg (kidney). Tissues from OTC-treated turkeys were processed directly for extraction and purification.
To each sample, 7.5 mL extraction buffer was added. After stirring for 10 min at 800 rpm, 7.5 mL methanol was added. The tubes were mixed on a vortex mixer for 15 s and centrifuged at 10 000´g for 10 min at +4°C. The supernatant was immediately transferred to polypropylene tubes and maintained for maximum 1 h at +4°C before cleanup. Cartridges for sample purification were prepared as follows: a frit was placed on the bottom of the empty reservoir, Chelating Sepharose Fast Flow Gel was slowly poured into the empty reservoir to obtain a bed height of 1 cm, and another frit was placed on top of the resin. The cartridge was washed with water (3´0.5 mL). Then 0.5 mL 10mM CuSO 4 + 5H 2 O followed by 0.5 mL water was added to obtain a blue layer perfectly horizontal on the upper third of the resin. The following operations were accomplished by gravity feed and the metal chelate affinity chromatography (MCAC) columns were always maintained wet.
A 6 mL volume of supernatant obtained from the sample extraction (corresponding to 0.4 g of tissue) was loaded into the cartridge. The cartridge was washed with 0.5 mL water, 0.5 mL methanol, 0.5 mL water, and 0.1 mL EDTA elution buffer. OTC was then eluted with 0.8 mL EDTA elution buffer into graduated 10 mL glass tubes. Liver and kidney samples were further diluted to a final volume of 1 mL with EDTA elution buffer, so that sample dilution factor was 2 for muscle and 2.5 for liver and kidney. All samples were transferred into a vial for LC analysis.
LC Analysis
The LC analyses were performed using the mobile phase reported above at a flow rate of 1 mL/min, with an injection volume of 100 m L. The run time was 15 min.
Method Validation
Linearity of the detector response was determined with OTC and 4-epi-OTC standard solutions over the ranges of 25-480 and 6.12-120 m g/L, respectively. The concentrations of OTC and 4-epi-OTC in standard solutions were selected considering the dilution factors applied to tissue samples after cleanup, i.e., 2.5 for liver and kidney, and 2 for muscle.
Selectivity was evaluated by comparing the chromatograms of blank and spiked samples obtained with the procedure reported; the retention times of tetracycline and chlortetracycline, structurally similar compounds licensed for veterinary use, were also determined.
Interday repeatability was determined by extraction, in sextuplicate (2 replicated per day for 3 days), of each of the tissues fortified with OTC and 4-epi-OTC. Every working day, a 3-point calibration curve was constructed by spiking blank samples as previously described.
The limit of detection (LOD) was calculated as 3 times the peak-to-peak noise determined at the retention time of OTC and 4-epi-OTC. The limit of quantitation (LOQ) was defined as the lowest concentration for which the method is validated with an accuracy and precision that fall within the ranges recommended by the EU (13) . To check the possible occurrence of 4-epi-OTC as a consequence of sample manipulation, 2 tubes containing the supernatant from each tissue spiked with OTC (at the highest concentration) were kept at +4°C for 24 h before cleanup.
Calculation of Withdrawal Times
All residues of OTC and 4-epi-OTC below the LOQ and above the LOD were calculated and reported exactly. The residues of 4-epi-OTC below the LOD were set to half the LOD, but when all the data of the time point were lower than the LOD, the results were excluded from the calculation.
Regression models were fitted to the logarithms of the muscle, liver, and kidney residues, expressed as the sum of OTC and 4-epi-OTC concentrations. Nonlinearity of each regression model was assessed using the "lack of fit" test. Homogeneity of variances was assessed using Barlett's method, and the normality of residuals was checked using the Shapiro-Wilk test. One-sided upper tolerance limits with a 95% confidence were calculated from these regression models, based on the equation of Stange (12) .
Results
OTC and 4-epi-OTC eluted at retention times of 6.2 ± 0.4 and 5.7 ± 0.5 min, respectively. Under the same conditions, tetracycline and chlortetracycline eluted after OTC with retention times of 8.6 ± 0.4 and 11.6 ± 0.6 min, respectively. The calibration curves for OTC and 4-epi-OTC were linear over the entire concentration ranges (25-480 and 6.12-120 m g/L, respectively).
No interfering peaks eluted at the retention times of OTC and 4-epi-OTC in the blank samples of all the matrixes. Typical chromatograms from blank, spiked, and positive samples (from treated birds) of muscle, liver, and kidney are shown in Figures 1-3 . Interday accuracy and precision determined at 3 concentration levels for each tissue are reported in Table 1 . The equations for the regression lines and correlation coefficients obtained from the analysis of blank sample tissues fortified with OTC and 4-epi-OTC are summarized in Table 2 . For OTC, the LOQs were validated at one-half the MRL, and the LODs were 4.7 m g/kg for muscle, 11.0 m g/kg for liver, and 9.3 m g/kg for kidney. The LOQs for 4-epi-OTC were validated at one-eighth the MRL, and the LODs were 6.2 m g/kg for muscle, 12.1 m g/kg for liver, and 10.1 m g/kg for kidney. In the samples fortified with OTC and maintained at +4°C for 24 h before cleanup, 4-epi-OTC was not detected and OTC recovery was about 80%.
The individual values of OTC and 4-epi-OTC residues in muscle, liver, and kidney of treated turkeys slaughtered after 1, 3, and 5 days of withdrawal are reported in Table 3 . OTC residues were detected in all tissue samples; 4-epi-OTC was found in muscle only on the first day after the end of treatment, with concentrations higher than LOQ in 3 out of 6 samples. Traces of 4-epi-OTC always lower than LOQ were detected in liver and kidney after 1 and 3 days of withdrawal, respectively, and at all sampling times. The tissue concentrations of 4-epi-OTC were always lower than OTC concentrations and never exceeded the upper concentration adopted for validation. One day after the end of treatment, the sum of OTC and 4-epi-OTC residues in kidney was below the MRL in all the birds killed. At that time, muscle and liver residues were higher than the corresponding MRLs and decreased to values less than the MRLs 3 days after withdrawal.
The linear regression model fitted the logarithms of the tissue residues, as the sum of OTC and 4-epi-OTC. There was no evidence of abnormality of the residuals or of unequal variances. The upper tolerance limits of residues for muscle, liver, and kidney were below the MRLs at 4.3, 3.2, and 1.7 days after withdrawal, respectively.
Discussion
The cleanup by MCAC was initially proposed by Farrington et al. (14) and used by others (15) (16) (17) (18) . This technique is based on the property of tetracyclines to act as avid chelators of copper ions and showed good selectivity and percentage of recovery of tetracyclines from spiked milk, eggs, and tissues. It was also suitable for detection of 4-epi-OTC (18) . However, the sample cleanup was somewhat cumbersome and time-consuming, as great volumes of extraction solvents were loaded on the MCAC column, and a further step on an XAD column (14) or an SDB-RPS extraction membrane (17) was added to purify and concentrate the sample. To improve the chromatographic performance and sensitivity of the method, gradient solvent programs (15, 16) and post-column derivatization with fluorescence detection were also used (17) . The procedure used for extraction and purification of OTC and 4-epi-OTC from turkey kidney, liver, and muscle was miniaturized by reducing the Chelating Sepharose column size and the amount of extraction solution loaded on-column. Then the cleanup and sample filtration were not necessary: the eluate from the Chelating Sepharose column was clear and free of particulate matter capable of fouling the column inlet. The eluate was directly analyzed by LC-UV at isocratic conditions, allowing separation of the parent compound and its 4¢ -epimer. The LC column was chosen after a preliminary assay comparing the efficiency of the polymeric reversed-phase-S (PLRP-S) column (100 Å, 5 m m, 150´4.6 id; Polymer Laboratories Ltd, Shropshire, UK), previously adopted (15) (16) (17) , and the LUNA C18(2) column. The latter gave a better resolution of OTC and 4-epi-OTC and improved peak shape and sensitivity, as expected due to its higher number of theoretical plates.
The method was validated at MRL values and at half and double the MRL values for OTC, as required by the EU (19) . Lower values (1/8, 1/4, and 1/2 MRL) were chosen for 4-epi-OTC because the expected concentrations of this derivative were too low for quantitative analysis using concentration ranges similar to those used for OTC. The LOQs appeared suitable for the residue depletion study. Dilution of the sample allowed separation of the peaks of interest from matrix interferences without affecting the required LOQ value.
Miniaturized MCAC improves the analysis performance and reduces costs, solvents, and extraction time. It is a specific extraction method for OTC and 4-epi-OTC; samples from incurred tissues prepared are free of chromatographic interferences, and peaks are readily identifiable. An additional advantage is that numerous samples may be processed at one time, and almost no hazardous waste is generated by this extraction procedure.
The absence of the 4-epi-OTC in the chromatograms of samples spiked only with OTC and held at 4°C for 24 h showed that the origin of the OTC derivative was not related to the sample manipulation. Nevertheless, 4-epi-OTC was found in tissues from treated turkeys, even if at very low concentrations. This indicates that 4-epi-OTC was probably formed in vivo and not during sample preparation. As already suggested (20, 21) , the origin of the 4¢ -epimer of the tetracyclines might be metabolic.
The experimental protocol of the residue depletion study simulated field conditions, and the reduced water intake of the first day was a consequence of the bitter taste of OTC-medicated water. The drug intake calculated on the basis of water consumption was within the scheduled dose rate limits (50-80 mg/kg bw). The withdrawal times calculated for OTC residues ranged from 1.7 days for kidney to 3.2 days for liver, and 4.3 days for muscle. These discrepancies are related to the initial tissue distribution of residues and not to the different depletion rates in target tissues. The half-lives of OTC residues in kidney, liver, and muscle, calculated from the regression line of log concentrations versus time data are 1.7, 1.1, and 0.9 days, respectively. At the first withdrawal time, the ratio of OTC residues in kidney and muscle is about 3 to 1 instead of 6 to 1, as usually observed in the major species. This peculiar distribution could be a consequence of the different physiology of birds and mammals and suggests the need for a lower MRL for OTC in bird kidney. However, due to the poor contribution of this tissue to the standard food package (10 g kidney compared to 300 g muscle and 100 g liver), the total intake of OTC residues would not change substantially.
In conclusion, to ensure safe residue concentrations in all target tissues of turkeys treated for 3 days with 400 mg/L OTC in drinking water, a 5-day withdrawal period should be adopted.
